Safety, Tolerability and Immunogenicity of PfSPZ Vaccine in an Age De-escalation Trial in Equatorial Guinea.
Clinical trial NCT02859350 · COMPLETED
Trial details
- NCT number
- NCT02859350
- Sponsor
- Sanaria Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-01
- Primary completion
- 2017-12-01
- Enrollment
- 135
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.